Novartis Halts Development of Investigational Drugs Zalbin, Mycograb

Drug Industry Daily
A A
Novartis has pulled the plug on two of its investigational drug candidates, including the hepatitis C drug Zalbin.

To View This Article:

Login

Subscribe To Drug Industry Daily